Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
09/2003
09/17/2003CN1443162A New combination of serotonin agonist (5HT2) and antagonist (5HT6) as pharmaceutical formulation
09/17/2003CN1443155A Compounds to treat alzheimer's disease
09/17/2003CN1443071A Neuroprotective 7-beta-hydroxysteroids
09/17/2003CN1443070A Apoptosis inhibiting composition comprising 15-keto-prostaglandin or derivative thereof
09/17/2003CN1443067A Analgesic and anti-inflammatory compositions containing cox-2 inhibitors
09/17/2003CN1443066A Use of dopamine D2/D3 receptor agonists to treat fibromyalgia
09/17/2003CN1443065A Pharmaceutical composition improved in peroral absorbability
09/17/2003CN1442197A New use of agastache rugosus oil
09/17/2003CN1442184A Medicine for treating depression and its preparation method
09/17/2003CN1442160A Nose smelling liquid possessing aromatic, inducing resuscitation, arousing brain, raising spirit action
09/17/2003CN1442155A Lulusu synthetic medicinal liquid
09/17/2003CN1442139A Medicinal composition for treating inflammation
09/17/2003CN1121403C Quinoxalinediones
09/17/2003CN1121374C Novel trienoic retinoid compounds and method
09/17/2003CN1121219C Novel process for manufacturing paroxetine solid dispersions
09/17/2003CN1121213C Method of preparing sustained release compositions
09/16/2003US6622036 Method for classifying and treating physiologic brain imbalances using quantitative EEG
09/16/2003US6620915 Monoclonal antibodies specific for integrin α-d subunit
09/16/2003US6620851 Methods for the treatment of neuropathic pain and other disorders using R(−)-ketoprofen
09/16/2003US6620847 Copolymer-1 improvements in compositions of copolymers
09/16/2003US6620845 For therapy and prophylaxis of neurological diseases
09/16/2003US6620840 Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
09/16/2003US6620839 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
09/16/2003US6620811 Isonicotin- and nicotinamide derivatives of benzothiazoles
09/16/2003US6620809 Substituted (dihydro)benzoxazine and (dihydro)benzothiazine compounds
09/16/2003US6620806 Estrogen agonist/antagonist to prevente myocardial infarction or stroke, maintaining or improving vascular reactivity, treat renal failure, peripheral arterial occlusive disease, coronary artery disease, or raynaud's phenomenon
09/16/2003US6620802 Methods of treating mild cognitive impairment using a glucocorticoid-specific receptor antagonist
09/16/2003US6620792 Monosialoganglioside GM1 or a derivative thereof, namely, the inner ester AGF2 and the methyl ester AGF4, suitable for the treatment of Parkinson's disease. A further object of the present invention is a therapy for Parkinson's Disease
09/16/2003US6620789 Compounds are provided that inhibit the interaction of an IGF with any one of its binding proteins and not to a human IGF receptor. These IGF agonist compounds, which include peptides, are useful to increase serum and tissue levels of active IGFs
09/16/2003US6620783 Human SMN-like protein (HSLP) and polynucleotides which identify and encode HSLP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating
09/16/2003US6620782 compounds having Formula I are potent inhibitors of caspases and apoptotic cell death. Therefore, the inhibitors of this invention can retard or block cell death in a variety of clinical conditions in which the loss of cells, tissues or
09/16/2003US6620432 In admixture with erodible matrix, for reliable controlled release of phenytoin sodium even after storage
09/16/2003US6620415 Parkinson's disease treatment
09/16/2003CA2558708A1 A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease
09/16/2003CA2274133C Novel substituted tetrahydropyridin derivatives, method of preparation and pharmaceutical compositions containing them
09/16/2003CA2267096C Pharmaceutical microspheres of valproic acid for oral administration
09/16/2003CA2249009C Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors
09/16/2003CA2235421C Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
09/16/2003CA2232116C Novel n-aryl piperidine compounds, process for their preparation and pharmaceutical compositions containing them
09/16/2003CA2231025C Novel compounds of 2-aminoindane, process for their preparation and pharmaceutical compositions containing them
09/16/2003CA2142610C Anabaseine derivatives useful in the treatment of degenerative diseases of the nervous system
09/16/2003CA2119463C Glial cell line-derived neutrophic factor
09/16/2003CA2078759C Novel carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace
09/16/2003CA2046429C Imide derivatives, and their production and use
09/12/2003WO2003075015A2 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents
09/12/2003WO2003074711A1 Expression cassette for persistence of expression of a gene of interest in muscle cells
09/12/2003WO2003074703A1 Novel transcriptional factor, dna thereof and use of the same
09/12/2003WO2003074681A1 Recombinant spores
09/12/2003WO2003074654A2 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
09/12/2003WO2003074564A1 Novel hemepeptide
09/12/2003WO2003074558A2 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, and treatments and animal models produced therefrom
09/12/2003WO2003074530A1 Bicyclic pyridine and pyrimidine p38 kinase inhibitors
09/12/2003WO2003074522A1 Process for preparing 3-(2-(4-(6-fluorobenzo(d) isoxazol-3-yl)-piperidin-1yl)-ethyl)-2-methyl-6,7,8,9-tetrahydro-4h-pyrido-(1,2-a) pyrimidin-4-one
09/12/2003WO2003074520A1 Thiadiazolylpiperazine derivatives useful for treating or preventing pain
09/12/2003WO2003074518A1 Thiazole derivatives and their use d2- and 5-ht1a-receptor ligands
09/12/2003WO2003074489A1 Cyclic n-substituted alpha iminocarboxylic acids for selectively inhibiting collagenase
09/12/2003WO2003074486A1 Azaspiro compounds for the treatment of pain
09/12/2003WO2003074483A1 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
09/12/2003WO2003074479A1 Semicarbazide derivatives and their use as antithrombotics
09/12/2003WO2003074081A1 SPECIFIC ANTIBODIES TO AMYLOID β PEPTIDE, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF
09/12/2003WO2003074080A1 Treatment of central nervous system damage
09/12/2003WO2003074053A1 Use of epothilones in the treatment of brain diseases associated with proliferative processes
09/12/2003WO2003074023A1 Aerosol formulations for pulmonary administration of medicaments to produce a systemic effect
09/12/2003WO2003074008A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003WO2003073994A2 Methods of treating nerve entrapment syndromes
09/12/2003WO2003073986A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003WO2003073983A2 Methods and compositions in treating pain using diacylglycerol kinase epsilon
09/12/2003WO2003051828A3 (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
09/12/2003WO2003051333B1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
09/12/2003WO2003045940A3 Benzazepine derivatives and their use as 5-ht ligands
09/12/2003WO2003041684A3 Injectable depot compositions and uses thereof
09/12/2003WO2003032969A3 Anti-glycation agents for preventing age-, diabetes-, and smoking-related complications
09/12/2003WO2002080979A3 Conjugate of hydroxyalkyl starch and an active agent
09/12/2003WO2002080966A3 Method for producing a vaccine containing autologous antibodies
09/12/2003WO2002072830A3 Proteins associated with cell growth, differentiation, and death
09/12/2003WO2002060871A3 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor
09/12/2003WO2002058695A9 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/12/2003WO2002040486A3 METHODS OF TREATING p38 KINASE-ASSOCIATED CONDITIONS AND PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS
09/12/2003WO2002032961A8 Novel polypeptides and nucleic acids encoding same
09/12/2003WO2002030447A3 Treatment of demyelinating diseases by administering gpe
09/12/2003WO2001095785A3 Modulation of immune response and methods based thereon
09/12/2003CA2478636A1 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, and treatments and animal models produced therefrom
09/12/2003CA2478528A1 Semicarbazide derivatives and the use thereof as antithrombotics
09/12/2003CA2478042A1 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents
09/12/2003CA2477874A1 Expression cassette for persistence of expression of a gene of interest in muscle cells
09/12/2003CA2477808A1 Methods of treating nerve entrapment syndromes
09/12/2003CA2477721A1 Bicyclic pyridine and pyrimidine p38 kinase inhibitors
09/12/2003CA2477715A1 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient
09/12/2003CA2477449A1 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003CA2477423A1 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003CA2477403A1 Use of epothilones in the treatment of brain diseases associated with proliferative processes
09/12/2003CA2477124A1 Azaspiro compounds for the treatment of pain
09/12/2003CA2474811A1 Process for preparing 3-(2-(4-(6-fluorobenzo(d) isoxazol-3-yl)-piperidin-1yl)-ethyl)-2-methyl-6,7,8,9-tetrahydro-4h-pyrido-(1,2-a) pyrimidin-4-one
09/12/2003CA2455447A1 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
09/11/2003WO2003074500A2 N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
09/11/2003WO2003074046A1 Antidepressant
09/11/2003US20030171584 6-Substituted pyrido-pyrimidines
09/11/2003US20030171564 Novel argS
09/11/2003US20030171556 Diagnosis and therapeutic treatment of Alzheimer's Disease; drug screening
09/11/2003US20030171440 Tramadol analogs and uses thereof
1 ... 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 ... 1833